Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.1.7 (
acetylcholinesterase
)
28,390
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The authors presented the results of a study of enzymuria (
cholinesterase
, gamma-glutamine transferase, alkaline phosphatase, beta-galactosidase and lactate dehydrogenase with separate determination of N- and M-subunits) in 20 patients with a mixed form of
glomerulonephritis
(GN), 36 with the nephrotic form of GN and 13 patients with the hematuric form of GN. The clinical importance of the determination of enzymatic activity in the urine in GN of children lies in the recognition of the degree of damage of the glomerular filter as well as the nephrothelium. Basing on enzymuria pathophysiological syndromes found in various combinations in the above forms of GN were identified. Three degrees of damage of the permeability of the glomerular filter were defined for high molecular proteins. Differences in individual values of the activity of some enzymes gave rise to differential-diagnostic coefficients as well as differential-diagnostic tables which could be used for differential diagnosis between the GN mixed and nephrotic forms.
...
PMID:[Clinical significance of enzymuria in glomerulonephritis in children]. 376 57
Metals of the platinum group have found important application in technology and industry. Compounds of these metals display a broad spectrum of toxic effects on the organism. In persons dealing with them in the production, they induce allergic occupational diseases of the respiratory passages, dermatoses, affections of the eyes. Their resorptive chronic effect in experiment is characterized by reduction in the body mass of the animals and the content of haemoglobin in the blood, by disturbances of the protein-synthesizing function of the liver, decreased
cholinesterase
activity in the blood, impaired carbohydrate and lipid metabolism, reduced concentrating capacity of the liver, development of
glomerulonephritis
. Platinum and platinoids irritate mucous membranes and skin. They penetrate the organism through intact skin. Data on the distribution of the metals in the organs and on their elimination from the organism are reported. Toxicity of the metals of the platinum group is correlated with valence of the compounds and with electron structure. MAC for milling and condensation aerosols of poorly soluble compounds (metal and its oxides) are recommended at 0.1 mg/m3. For aerosols of all soluble compounds of platinum and platinoids, MAC of 0.001 mg/m3 are recommended.
...
PMID:Industrial toxicology of metals of the platinum group. 671 73
A 47-year-old woman who was homozygous for a silent
cholinesterase
gene (hereditary serum
cholinesterase
deficiency) presented with nephrotic syndrome and hyperlipidemia. Renal biopsy performed in 1986 demonstrated mesangial proliferative
glomerulonephritis
. Four years later, a second biopsy revealed progression with mesangial interpositions and severe lipid deposition in the glomeruli, tubules and interstitium. This is the first case of hereditary serum
cholinesterase
deficiency accompanied by renal disease. Serum cholinesterase deficiency may be related to hyperlipidemia and abnormal lipid deposition in the kidney, which promotes the progression of renal disease.
...
PMID:Hereditary serum cholinesterase deficiency associated with severe lipid deposition in the kidney. 850 26